# Novo Nordisk A/S will integrate OpenAI's artificial intelligence across the company to accelerate drug development.

*business · news · 2026-04-14 · NDTV Profit*

## Key points

- Novo Nordisk will fully integrate OpenAI's AI across research, manufacturing, and commercial operations by year-end.
- The new OpenAI partnership extends beyond Novo's previous internal use of a custom ChatGPT version.
- Pilot programs using OpenAI's AI will start in R&D, manufacturing, and commercial units before full rollout.
- Novo aims to use OpenAI's AI to accelerate drug target identification and improve clinical trial design.

**Companies:** Novo Nordisk A/S, Nvidia Corp, Eli Lilly & Co
**Countries:** Denmark, United States

[Read the full story on NDTV Profit](https://www.ndtvprofit.com/business/novo-taps-openai-to-speed-development-of-new-obesity-drugs-11356071)

---

Canonical: https://newsio.io/n/5a6367f7-9e48-4578-9601-266695b842bf/novo-nordisk-as-will-integrate-openais-artificial-intelligence-across-the-compan
Summarized by Newsio from NDTV Profit. https://newsio.io/how-it-works